Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-17-009649

Options or other derivatives

  • Director acquired 160,227 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rubin Steven D · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-02-14 Grant or award : show line 1 in the form Company Stock Option +160,227 $0.11 $17,625 160,227 D
Loading xslF345X03/v459869_form4.xml…